Joao Siffert M.D. is SVP & R&D at AVANIR PHARMACEUTICALS, INC. (AVNR). They have made 3 open-market trades across 2 companies since 2012, most recently 2022-12-20.
CIK 0001534986
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $123K since 2012, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DSGN | BUY | 2022-12-19 | 2022-12-21 | $8.39 | $115K | +7.0% | +0.5% | -29.8% |
| AVNR | SELL · 10b5-1 | 2014-12-18 | 2014-12-22 | $16.93 | $262K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2014-10-24 | 2014-10-24 | $11.80 | $99K | N/A | N/A | N/A |
| AVNR | SELL | 2014-05-28 | 2014-05-30 | $5.18 | $70K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2013-12-18 | 2013-12-20 | $2.63 | $16K | N/A | N/A | N/A |
| AVNR | SELL · 10b5-1 | 2013-09-18 | 2013-09-19 | $4.22 | $89K | N/A | N/A | N/A |
| AVNR | BUY | 2012-05-10 | 2012-05-14 | $2.96 | $8K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.